Drugs / Modified Vaccinia Virus Ankara
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00046397 | Sep 2002 → Aug 2005 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Modified Vaccinia Virus Ankara | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00046397 ↗ |
| Known as | MVA | “experimental vaccine called Modified Vaccinia Virus Ankara (MVA)” NCT00046397 ↗ |
| Modality | Vaccine | “experimental vaccine called Modified Vaccinia Virus Ankara (MVA)” NCT00046397 ↗ |
| Route | Intramuscular | “administered by intramuscular (IM) injection” NCT00046397 ↗ |